Grab your lunch and join us on July 15th for our Lunch Series!
Join us on Zoom with Yvette P. Quantz, RDN, LDN, Founder of Affy Health, LLC. This session will discuss the framework for delivering meaningful nutrition messages to patients.
Register with the QR code below!
#LSU’s Pennington Biomedical Research Center is pleased to announce that Dr. Owen Carmichael was awarded the James W. and Neil Ann Parks Professorship for Dementia Research, Prevention and Treatment: https://t.co/fgMsn0qp3w.
James and Neil Ann Parks are longtime supporters of Pennington Biomedical. They intend for this professorship to be part of their legacy in understanding, preventing and treating dementia, Alzheimer’s disease, Lewy body dementia and other diseases of the brain, and believe that through this work, new diagnostics and treatments will be developed until a cure is found. Endowed professorships are among the highest academic honors bestowed upon a faculty member and recognize excellence in research, scholarship and leadership. #PBRCresearch
#LSU’s Pennington Biomedical Research Center is pleased to announce that Dr. Owen Carmichael was awarded the James W. and Neil Ann Parks Professorship for Dementia Research, Prevention and Treatment: https://t.co/fgMsn0qp3w.
James and Neil Ann Parks are longtime supporters of Pennington Biomedical. They intend for this professorship to be part of their legacy in understanding, preventing and treating dementia, Alzheimer’s disease, Lewy body dementia and other diseases of the brain, and believe that through this work, new diagnostics and treatments will be developed until a cure is found. Endowed professorships are among the highest academic honors bestowed upon a faculty member and recognize excellence in research, scholarship and leadership. #PBRCresearch
In my piece just published @Nature I argue that #Obesity can be a disease — but not in every case.
We need accurate clinical diagnosis for obesity, not uniform labels.
https://t.co/anxrRBxWRf
In medicine, diseases are typically defined bottom-up: from bedside observations of consistent patterns of clinical manifestations, trajectories and outcomes. That consistency enables meaningful prediction of prognosis, discovery of biological mechanisms, meaningful study of treatment responses in clinical trials, and deeper understanding of causes.
Obesity’s health impact has largely been defined in reverse — top-down from population-level statistics. But group-level associations do not directly translate into illness in individuals.
At the individual level, obesity does not always equate to ill health, and the “disease” label does not always fit.
Distinguishing clinical obesity (active disease) from preclinical obesity (a risk state) better serves care, policy, research, and advocacy— one that recognizes the heterogeneity of obesity and places the individual at the centre.
Unlike uniform disease labels, a clinical definition allows us to treat disease as disease and risk as risk — enabling proportionate, personalised care and bringing obesity into 21st-century medicine.
@TheLancetEndo@TheLancet@EricTopol@WorldObesity@IfsoSecretariat@ADA_DiabetesPro@EASDnews@ObesitySociety@rvcohen@NeilFlochMD@PSchauerMD@AgrawalNina@ProfBatterhamMD
Personalizing the future of healthcare: Researchers at @PBRCNews and @LSUHealthNO are advancing NIH-backed precision nutrition research to better understand how genetics, metabolism, and behavior shape obesity and diabetes treatment. Explore LSU's research growth: https://t.co/MWZE7BAHAC
A new study from @nyulangone compared #Semaglutude to bariatric surgery: People in the surgery group shed an average of 25.7 percent of their total body weight over two years, while those in the medication group lost only 5.3 percent because the GLP-1 group stopped the medication.
I had the privilege of getting to know Ele Ferrannini only in the last 3-4 years, but it was enough to appreciate his truly brilliant mind, remarkable clarity, and gracious presence. A giant in diabetes research who will be deeply missed.
Metabolic Bariatric Surgery is a powerful tool but long-term success depends on daily habits. 🌿
After MBS, nutrition isn’t just about eating less: it’s about enough protein, preventing deficiencies, protecting muscle mass, and building sustainable habits.
#pt2
HURRY UP 📢
Take advantage of the Early Bird rate and join us at IFSO 2026 Toronto!
⌛ Early Bird ends 10 June 2026
📍 Toronto, Canada
📅 September 1-4, 2026
👉 Learn more and register: https://t.co/79SyZISwi1
@ObesityCan@Cabps_Obesity@IFSO_NAC
🚨ABSTRACT DEADLINE EXTENDED! 🚨
The new deadline to submit an abstract for the Louisiana Obesity Conference is now Monday, June 8th!
Use the QR code or the link for more information and to submit!
👉https://t.co/kbJzkIZfS3
Childhood obesity affects too many #Louisiana families, but new solutions are being developed right here in our state. This morning, Dr. Amanda Staiano from Pennington Biomedical and Dr. Melissa Holland from @ololhealth joined @talk1073 to discuss the COACH trial, a new study that is helping families build healthier habits through primary care clinics across Louisiana and Tennessee.
The program focuses on children ages 5 to 17 who fall above the 95th percentile for height and weight. According to the researchers, more than one-in-five children nationwide now live with obesity. The most severe cases can lead to serious health issues, including high blood pressure, sleep apnea, asthma, prediabetes, and high cholesterol. LIsten to the interview at https://t.co/oP4IKFUDTG. #Solutions #CellstoSociety #LSUresearch #ChildhoodObesity #COACHTrial #LouisianaHealth
Metabolic Bariatric Surgery is a powerful tool but long-term success depends on daily habits. 🌿
After MBS, nutrition isn’t just about eating less: it’s about enough protein, preventing deficiencies, protecting muscle mass, and building sustainable habits.
#pt1
Despite ongoing efforts, childhood obesity prevalence in the U.S. has continued to increase over the past 10 years, with over 1-in-5 children and adolescents affected by obesity. Through a grant from the Patient-Centered Outcomes Research Institute provided to Pennington Biomedical and Vanderbilt University Medical Center, researchers are studying the ideal “dose” of behavioral interventions to treat childhood obesity in rural and minority communities across #Louisiana and Tennessee. #LSUresearch #PBRCresearch #PCORI #lalege #lagov
Research funding is more than a number. It is a direct investment in #Louisiana’s future. When #LSU wins a research grant, those dollars immediately fuel discovery, innovation, jobs, healthcare advancement and economic growth. They support local businesses, strengthen national security, attract industry and help keep talent in Louisiana.
A powerful example is the Metabolic Basis of Disease Center of Biomedical Research Excellence at Pennington Biomedical Research Center. Its recent #NIH grant renewal represents a $10.9 million investment over five years to continue supporting emerging scientists studying how nutrition and metabolism impact health and disease #LSUresearch #PBRCresearch #lalege #lagov